setmelanotide (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Obesity

Pending FDA approval for obesity associated with genetic defects upstream of the melanocortin-4 receptor in the leptin-melanocortin pathway, which includes pro-opiomelanocortin (POMC) deficiency and leptin receptor (LEPR) deficiency

Next:

Pharmacology

Mechanism of Action

Melanocortin-4 receptor (MC4R) agonist designed to restore impaired MC4R pathway function caused by genetic variants that occur upstream of the receptor

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.